华绿生物 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	1.0B	996.0M	752.0M	578.0M	609.0M
Revenue Growth %	3.6%	32.4%	30.1%	-5.1%	--
Total Revenue	1.0B	996.0M	752.0M	578.0M	609.0M
Cost Of Revenue	971.0M	862.0M	629.0M	540.0M	443.0M
+Gross Profit	61.0M	134.0M	123.0M	38.0M	166.0M
Gross Margin %	5.9%	13.5%	16.4%	6.6%	27.3%
Total Operating Cost	1.1B	970.0M	688.0M	577.0M	487.0M
Selling Expenses	10.8M	9.5M	5.5M	6.5M	6.1M
Admin Expenses	67.7M	70.8M	44.0M	30.9M	27.5M
Rd Expenses	14.6M	16.5M	14.0M	8.6M	8.8M
Finance Expenses	7.9M	136,700	-9.5M	-10.2M	1.5M
+Operating Income	-44.1M	27.2M	80.9M	17.0M	134.0M
Operating Margin %	-4.3%	2.7%	10.8%	2.9%	22.0%
Non Operating Income	541,700	211,400	1,300	57.00	33,700
Non Operating Expenses	733,800	1.0M	941,100	226,600	2.0M
Investment Income	86,600	540,200	4.3M	2.0M	2.0M
Fair Value Change Income	--	-173,800	-57,800	235,500	27,600
Asset Disposal Income	-1.5M	-10.9M	-1.3M	-261,900	-14,000
Asset Impairment Loss	11.9M	8.3M	3.6M	193,100	162,600
Other Income	11.5M	11.2M	14.1M	13.4M	10.3M
Income Before Tax	-44.3M	26.4M	80.0M	16.8M	132.0M
Income Tax	145,100	1.78	2.3M	506,900	146,400
+Net Income	-44.4M	26.4M	77.7M	16.3M	132.0M
Net Margin %	-4.3%	2.6%	10.3%	2.8%	21.7%
Net Income Attributable	-47.6M	30.3M	78.3M	15.5M	133.0M
Minority Interest	3.1M	-4.0M	-586,400	775,900	-288,700
Eps Basic	-0.41	0.26	0.67	0.14	1.30
Eps Diluted	-0.41	0.26	0.67	0.14	1.30

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	361.0M	410.0M	432.0M	411.0M	192.0M
Trading Financial Assets	--	--	100.0M	359.0M	39.1M
Accounts Receivable	16.7M	18.7M	12.5M	36.9M	15.5M
Notes Receivable	--	--	--	--	--
Notes And Accounts Receivable	16.7M	18.7M	12.5M	36.9M	15.5M
Prepayments	2.6M	6.1M	5.0M	1.7M	723,000
Inventory	196.0M	188.0M	157.0M	108.0M	83.8M
Total Current Assets	580.0M	628.0M	710.0M	920.0M	336.0M
Fixed Assets	--	1.2B	881.0M	777.0M	659.0M
Fixed Assets Total	1.4B	1.2B	881.0M	777.0M	659.0M
Construction In Progress	--	93.6M	292.0M	83.7M	92.4M
Construction In Progress Total	95.3M	93.6M	292.0M	83.7M	92.4M
Intangible Assets	58.0M	58.5M	51.4M	52.4M	53.3M
Long Term Deferred Expenses	37,500	268,900	525,400	599,600	37,800
Total Non Current Assets	1.7B	1.5B	1.3B	957.0M	829.0M
Total Assets	2.3B	2.1B	2.0B	1.9B	1.2B
Short Term Borrowings	--	--	14.0M	50.1M	40.0M
Accounts Payable	73.3M	78.5M	56.8M	38.3M	29.2M
Advance Receipts	--	--	--	--	--
Contract Liabilities	3.4M	3.6M	8.4M	2.2M	2.9M
Total Current Liabilities	223.0M	234.0M	185.0M	172.0M	137.0M
Long Term Borrowings	303.0M	170.0M	227.0M	210.0M	133.0M
Total Non Current Liabilities	564.0M	317.0M	273.0M	267.0M	177.0M
Total Liabilities	786.0M	551.0M	458.0M	439.0M	314.0M
Paid In Capital	120.0M	118.0M	117.0M	117.0M	43.8M
Capital Reserve	916.0M	873.0M	844.0M	841.0M	318.0M
Surplus Reserve	48.4M	22.0M	22.0M	20.9M	20.9M
Retained Earnings	438.0M	535.0M	528.0M	451.0M	465.0M
Minority Equity	27.4M	20.3M	12.2M	8.7M	3.2M
Equity Attributable	1.5B	1.5B	1.5B	1.4B	848.0M
Total Equity	1.5B	1.6B	1.5B	1.4B	851.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	1.0B	985.0M	782.0M	559.0M	602.0M
Tax Refunds Received	--	--	8,100	213,700	--
Total Operating Cash Inflow	1.1B	1.0B	803.0M	600.0M	620.0M
Cash Paid For Goods	695.0M	628.0M	461.0M	370.0M	313.0M
Cash Paid To Employees	203.0M	199.0M	140.0M	131.0M	95.2M
Taxes Paid	897,100	1.4M	2.6M	414,100	908,900
Total Operating Cash Outflow	917.0M	844.0M	624.0M	517.0M	421.0M
Operating Cash Flow	138.0M	167.0M	180.0M	83.1M	199.0M
Total Investing Cash Inflow	56,300	202.0M	567.0M	223.0M	193.0M
Total Investing Cash Outflow	268.0M	324.0M	572.0M	867.0M	348.0M
Investing Cash Flow	-268.0M	-123.0M	-5.3M	-644.0M	-155.0M
Cash From Borrowings	251.0M	75.3M	142.0M	170.0M	112.0M
Dividends And Interest Paid	33.6M	35.6M	2.7M	35.8M	28.8M
Debt Repayments	134.0M	130.0M	157.0M	55.8M	89.4M
Total Financing Cash Inflow	280.0M	104.0M	146.0M	781.0M	116.0M
Total Financing Cash Outflow	199.0M	171.0M	160.0M	102.0M	118.0M
Financing Cash Flow	80.7M	-66.4M	-14.0M	680.0M	-2.2M
Net Change In Cash	-49.8M	-22.3M	161.0M	119.0M	42.0M
Ending Cash Balance	360.0M	409.0M	432.0M	271.0M	152.0M
Capex	268.0M	224.0M	408.0M	204.0M	191.0M